UY33935A - Formulación de película bucodispersable estable - Google Patents

Formulación de película bucodispersable estable

Info

Publication number
UY33935A
UY33935A UY0001033935A UY33935A UY33935A UY 33935 A UY33935 A UY 33935A UY 0001033935 A UY0001033935 A UY 0001033935A UY 33935 A UY33935 A UY 33935A UY 33935 A UY33935 A UY 33935A
Authority
UY
Uruguay
Prior art keywords
stable
buddispersable
formulation
film
active pharmaceutical
Prior art date
Application number
UY0001033935A
Other languages
English (en)
Inventor
Chang Wook Jun
Original Assignee
Chabio & Diostech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chabio & Diostech Co Ltd filed Critical Chabio & Diostech Co Ltd
Publication of UY33935A publication Critical patent/UY33935A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente revelación se relaciona con una formulación de película bucodispersable estable que contiene montelukast como ingrediente farmacéutico ac tivo u otros ingredientes farmacéuticos activos diversos en la cual se reduce la descomposición de estos ingredientes activos lo cual conduce a un contenido bajo de impurezas durante el almacenamiento .
UY0001033935A 2011-03-04 2012-03-02 Formulación de película bucodispersable estable UY33935A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020110019407A KR101077468B1 (ko) 2011-03-04 2011-03-04 안정한 경구용 속용 필름 제제

Publications (1)

Publication Number Publication Date
UY33935A true UY33935A (es) 2012-06-29

Family

ID=45396903

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033935A UY33935A (es) 2011-03-04 2012-03-02 Formulación de película bucodispersable estable

Country Status (5)

Country Link
KR (1) KR101077468B1 (es)
AR (1) AR085610A1 (es)
TW (1) TW201302248A (es)
UY (1) UY33935A (es)
WO (1) WO2012121461A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6200432B2 (ja) * 2011-12-26 2017-09-20 エスケー ケミカルズ カンパニー リミテッド モンテルカストまたはその薬学的に許容可能な塩を含む経口投与用フィルム
KR101546667B1 (ko) 2012-05-03 2015-08-25 주식회사 씨엠지제약 물성 및 쓴맛 차폐효과가 향상된 실데나필 경구용 속용 필름
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9707184B2 (en) 2014-07-17 2017-07-18 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
KR101538985B1 (ko) * 2014-09-02 2015-07-24 주식회사 서울제약 타다라필 구강붕해필름 및 이의 제조방법
CA2964628A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN105769825A (zh) * 2014-12-24 2016-07-20 广州朗圣药业有限公司 一种孟鲁司特钠的口腔膜剂及其制备方法
CN104784157B (zh) * 2015-04-04 2018-06-26 齐鲁制药有限公司 一种稳定的孟鲁司特口腔薄膜剂
US9949934B1 (en) * 2016-10-20 2018-04-24 Intelgenx Corp. Device and method of treating conditions associated with neuroinflammation
JP2020500220A (ja) 2016-11-15 2020-01-09 クラリア ファーマ ホールディング エービー 医薬製剤
BR112019018388A2 (pt) * 2017-03-30 2020-04-07 Intelgenx Corp método de tratamento e dispositivo para aumentar a disponibilidade biológica de antagonistas de receptor de leucotrieno
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030211136A1 (en) * 1998-09-25 2003-11-13 Neema Kulkarni Fast dissolving orally consumable films containing a sweetener
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
KR20050048056A (ko) * 2003-11-18 2005-05-24 (주)케이비피 경구용 소모 필름 조성물
AU2006337648A1 (en) * 2006-02-09 2007-08-16 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulations of montelukast sodium
KR100855566B1 (ko) * 2006-09-12 2008-09-03 (주) 아모젠 경구용 소모성 필름
AU2008316284A1 (en) 2007-10-25 2009-04-30 Merck Frosst Canada Ltd. Novel crystalline salts of montelukast
KR20100086140A (ko) * 2009-01-22 2010-07-30 일동제약주식회사 몬테루카스트를 활성성분으로 함유하는 구강 내 속붕해정 조성물 및 그 제조방법
KR101074271B1 (ko) * 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름

Also Published As

Publication number Publication date
WO2012121461A1 (ko) 2012-09-13
TW201302248A (zh) 2013-01-16
KR101077468B1 (ko) 2011-11-07
AR085610A1 (es) 2013-10-16

Similar Documents

Publication Publication Date Title
UY33935A (es) Formulación de película bucodispersable estable
AR122552A2 (es) Composición acuosa de inmunoglobulina estable durante el almacenamiento y método para estabilizar una composición de inmunoglobulina
PH12015502542A1 (en) Stabilized pemetrexed formulation
MX351584B (es) Formulacion farmaceutica acuosa de tapentadol para administracion oral.
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2016015772A (es) Composiciones orales que contienen fuentes de ion de zinc, estaño y fluoruro.
MX340591B (es) Formulaciones de liberacion inmediata y formas de dosis de gamma-hidroxibutirato.
PH12015500850A1 (en) Stable preservative-free mydriatic and anti-inflammatory solutions for injection
NZ712270A (en) Pharmaceutical composition of s-ketamine hydrochloride
EA201592227A1 (ru) Стабильные растворы объединенных активных фармацевтических ингредиентов для перорального применения
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
AR094012A1 (es) Composiciones estables con peroxido para el cuidado oral
HK1150373A2 (en) Disinfectant and antiseptic formulation having reduced iodine content
PH12015500834B1 (en) Oral composition
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
BR112016015190A8 (pt) Composição farmacêutica livre de antioxidante e método de preparação da mesma
PH12016502544A1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
BR112014017448A2 (pt) composição dermocosmética contendo como princípio ativo, uma combinação sinérgica de prata coloidal e ácido desoxirribonucleico
MX358798B (es) Formulacion de aroma y fragancia (v).
EA201500128A1 (ru) Педиатрические жидкие композиции для перорального введения, содержащие непадутант
UA75204U (uk) Спазмолітичний та седативний лікарський засіб у формі м'яких желатинових капсул
EA201500198A1 (ru) Стабильная фармацевтическая композиция в форме назального спрея, содержащая кеторолак
MY177091A (en) Sterically stabilized palmitoleic acid liposome
IN2014MU01179A (es)
UA42862U (uk) ЗАСТОСУВАННЯ М'ЯКОЇ ЛІКАРСЬКОЇ ФОРМИ, ЯКА МІСТИТЬ АКТИВНУ РЕЧОВИНУ β-ФЕНІЛЕТИЛАМІД 2-ОКСИСУКЦИНАНІЛОВОЇ КИСЛОТИ, ДЛЯ ЛІКУВАННЯ ОПІКОВИХ УРАЖЕНЬ ШКІРИ

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20201019